Sanjay Kumar Elangovan (@sanjaylangval) header
Sanjay Kumar Elangovan (@sanjaylangval) profile picture

Investment Director at @XponentTribe

Chennai, India
Joined January 2019
Photo by Sanjay Kumar Elangovan (@sanjaylangval)Photo by Sanjay Kumar Elangovan (@sanjaylangval)Photo by Sanjay Kumar Elangovan (@sanjaylangval)Photo by Sanjay Kumar Elangovan (@sanjaylangval)Photo by Sanjay Kumar Elangovan (@sanjaylangval)Photo by Sanjay Kumar Elangovan (@sanjaylangval)Photo by Sanjay Kumar Elangovan (@sanjaylangval)Photo by Sanjay Kumar Elangovan (@sanjaylangval)Photo by Sanjay Kumar Elangovan (@sanjaylangval)
Sanjay Kumar Elangovan retweeted
The longer I invest the more I realize you get 1-2 great opportunities every few years. The rest of the time is spent wondering if you will ever get another great opportunity again and convincing yourself to own mediocre opportunities while you wait. Mediocrity is the price you pay for impatience. microcapclub.com/active-pati…
54
81
7
1,315
79,795
Sanjay Kumar Elangovan retweeted
Today's Bulk Deals on NSE - 06.11.2026 𝗕𝗶𝗹𝗹𝗶𝗼𝗻𝗯𝗿𝗮𝗶𝗻𝘀 𝗚𝗮𝗿𝗮𝗴𝗲 𝗩𝗲𝗻𝘁𝘂𝗿𝗲𝘀 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 Peak XV Partners Investments VI-1 sold 60,213,215 shares at Rs. 215.20 𝗔𝗹𝗶𝘃𝘂𝘀 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 Nirma Limited sold 2,846,300 shares at Rs. 1,370.00 Nirma Limited sold 833,700 shares at Rs. 1,422.29 Bandhan Mutual Fund bought 855,971 shares at Rs. 1,370.00 Param Capital bought 729,729 shares at Rs. 1,370.00 𝗩𝟮 𝗥𝗲𝘁𝗮𝗶𝗹 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 Ricon Commodities Private Limited sold 9,865,000 shares at Rs. 160.00 Aditya Kumar Halwasiya bought 8,300,000 shares at Rs. 160.00 Ram Chandra Agarwal sold 6,260,000 shares at Rs. 160.00 𝗝𝗦𝗪 𝗖𝗲𝗺𝗲𝗻𝘁 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 Synergy Metals Investments Holding Limited sold 19,098,281 shares at Rs. 120.50 Nomura Funds Ireland PLC Nomura Funds Ireland India Equity Fund bought 12,000,000 shares at Rs. 120.50 𝗠𝗠 𝗙𝗼𝗿𝗴𝗶𝗻𝗴𝘀 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 Apurva Mahesh Shah sold 270,000 shares at Rs. 620.02 𝗪𝗶𝗻𝗱𝗹𝗮𝘀 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 Stellar Wealth Partners India Fund I LP bought 150,500 shares at Rs. 1,020.42 𝗔𝗽𝘀𝗶𝘀 𝗔𝗲𝗿𝗼𝗰𝗼𝗺 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 Kashmira Ajay Patel sold 160,000 shares at Rs. 468.18 Solidarity Micro Cap Emerging Leader AIF bought 94,600 shares at Rs. 468.00 𝗦𝗮𝗶 𝗦𝗶𝗹𝗸𝘀 (𝗞𝗮𝗹𝗮𝗺𝗮𝗻𝗱𝗶𝗿) 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 Capri Global Ventures Private Limited bought 824,810 shares at Rs. 86.60 𝗛𝗚𝗦 (𝗜𝗻𝗱𝗶𝗮) 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 Rohan Gupta bought 234,000 shares at Rs. 163.36 Vijit Growth Fund bought 122,400 shares at Rs. 163.29 𝗦𝗵𝗶𝘃 𝗔𝘂𝗺 𝗦𝘁𝗲𝗲𝗹𝘀 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 Capital One Share and Services bought 75,000 shares at Rs. 544.01 Moksh Trading Private Limited sold 75,000 shares at Rs. 544.00 𝗔𝗴𝗮𝗿𝘄𝗮𝗹 𝗧𝗼𝘂𝗴𝗵𝗲𝗻𝗲𝗱 𝗚𝗹𝗮𝘀𝘀 𝗜𝗻𝗱𝗶𝗮 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 A M Lodha & Sons (HUF) sold 168,000 shares at Rs. 169.03 𝗥𝗮𝗽𝗽𝗶𝗱 𝗩𝗮𝗹𝘃𝗲𝘀 (𝗜𝗻𝗱𝗶𝗮) 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 Marwadi Chandarana Intermediaries Brokers Private Limited bought 50,400 shares at Rs. 384.84 Ashok Kumar Dhariwal sold 34,200 shares at Rs. 385.00 𝗘𝘅𝗶𝗺 𝗥𝗼𝘂𝘁𝗲𝘀 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 Expertpro Realty Private Limited sold 221,600 shares at Rs. 71.66 𝗠𝗮𝗿𝘂𝘀𝗵𝗶𝗸𝗮 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 Mansi Share and Stock Broking Private Limited sold 99,600 shares at Rs. 120.13 𝗚𝗿𝗲𝗲𝗻 𝗔𝘀𝗶𝗮 𝗜𝗺𝗽𝗲𝘅 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 M7 Global Fund PCC - Aerion sold 139,200 shares at Rs. 72.00 Aikyata Advisory LLP bought 137,600 shares at Rs. 72.00 𝗔𝗔𝗔 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 M7 Global Fund PCC - Cell Dewcap Fund sold 95,000 shares at Rs. 96.15 𝗩𝗶𝗻𝗲𝗲𝘁 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝗶𝗲𝘀 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 Jayant Vijay bought 100,000 shares at Rs. 36.80 Oleander Financial Technologies Pvt Ltd | SEBI Registered Research Analyst | INH000022491 oleander.smallcase.com | t.me/oleanderinsights
1
1
2
2,050
Sanjay Kumar Elangovan retweeted
In 1971, India used L-70 anti-aircraft guns to defend airfields against attacking aircraft. During Operation Sindoor, upgraded versions of the same gun were used against incoming drones. The gun still fires shells. What improved was its ability to find, follow and aim at a target, through daylight and thermal cameras, a laser rangefinder, automatic tracking and a digital fire-control computer. Similar upgrades are happening across military equipment, with guided bombs, better missile seekers and more capable radars on aircraft. A modern weapon is increasingly an electronics system with a weapon attached to it. Our Q2FY27 letter is on Indian defence electronics. Here's what we learned 🧵
3
6
46
3,394
Personal Update: After five and a half years at @ithoughtpms, where I built my foundation as an investor, I'm moving on. Grateful for every lesson. New chapter: Investment Director at @XponentTribe, joining @kshayjogani, Sagar & a tribe of curious, intellectually honest people!
23
3
1
194
25,357
Shilpa Medicare wouldn't have been a surprise if one followed my questions in their concall 😅 They even have a website for their semiconductor chemicals/polymers portfolio: shilpasemicon.com/
Replying to @ResearchSOIC
The chemical ecosystem is forming too. > Shilpa Medicare (was a surprise for us too) , Sumitomo Chemical (moving from agro to niche semi chemicals), Baba Fine Chemicals working on lithography and packaging chemicals (photoacid generators, monomers, photo-definable polyimides) > Most projects still at pilot stage, ~2 years to materialise > Baba Fine Chem is already commercial, entirely export today, management optimistic on domestic demand building > Navin Fluorine: several advanced materials products already commercial, a few in pilot stages. But were very confident of scaling this business to new trajectory in next 4-5 years
1
16
2
224
41,150
Sanjay Kumar Elangovan retweeted
Looking at the export data, order book and earnings visibility of many small caps, does it make sense to stay invested in small caps this cycle and not hide in large caps? Did any small cap do well (relatively) in 2018 because of good earnings?
4
1
36
8,861
Sanjay Kumar Elangovan retweeted
Intelligence is more abundant than patience.
“Once at Flame university, I had put up a list of all companies which went up 100 times.” “I asked the audience, Is there anybody here who has not bought any of these names?” “There was not a single hand which went up. So, effectively all of us end up owning a 100 bagger at some point in life. The sad part is that we don’t have patience.” - Durgesh Shah. Src: @CFAinstitute India
2
8
27
7,391
Sanjay Kumar Elangovan retweeted
If public sector banks can't be scammed anymore does it mean huge event risks for many private sector companies... Moat is gone ?☺
1
4
3
24
Sanjay Kumar Elangovan retweeted
I guessed Shashi Jagadisan was on the way out last week itself. This video talks of the emerging scenario. என்ன நடக்கும் என்று கணித்து நாம் வியுகம் அமைத்து முதலீடு செய்யும் நேரம். @muthaleetukaLam உங்களை அப்படி சிந்திக்கத் தூண்டும் களம். Follow us on youtube. வேற level Content கிடைக்கும் ஒரே இடம். youtu.be/WMnI-_blTYE?si=loMW…
10
7
1
99
13,989
If CDMO companies working on innovator peptides are getting such multiples, wonder what Indian peptide innovators will get when their drugs start.
If CDMO companies working on innovator molecules are getting such multiples, wonder what Indian innovators will get when their drugs start.
6
105
17,879
Note - Peptides are not limited to pharma. AgChem has peptides too.
1
8
2,313
Sanjay Kumar Elangovan retweeted
BIG - Bengal Investment Group: The Beginning of a Dream bengalinvestmentgroup.in If you're in Kolkata and want to attend our sessions, register your contact details here, and we will notify you of upcoming sessions. intelsense.substack.com/p/bi…
3
33
5
52
28,562
Zaggle is an example of Financial Engineering 101. Similar to Banks, you can decide the growth rate by playing around with the inputs. Banks = Loan Growth. Zaggle = Propel Points or Program Fees You either get growth or cashflow. Simple, if Growth rate > ROE, you need equity.
2
45
4,962
Sanjay Kumar Elangovan retweeted
Direct comparison with Wuxi. Indian CRDMO continues to mature.
3
27
2,933
Sanjay Kumar Elangovan retweeted
People are asking (mostly deliberately) on TAM-increasing questions on concalls these days. Especially when they are invested from the past. Because TAM-increasing is P/E increasing - and who doesn’t love a higher and highest P/E. It’s not a curious question(s) - it’s P/E qns.
2
12
2,358
Sanjay Kumar Elangovan retweeted
#Lauruslab Nov’22 - @alphaideas event in Mumbai I said “Laurus entered the decade at 3000 cr mcap. Will exit at 3 lac cr mcap” Mcap then was 20k, everyone laughed. Nov’23 - same event- repeated same statement. Mcap then was 15k - everyone mocked Nov’25 - same event- again same statement. Mcap was 50k - everyone got serious Aug’26 - 1 lac cr MCap If Direction is right, destination is certain
31
61
2
969
89,855
Sanjay Kumar Elangovan retweeted
Summarising returns over last 24 years, including the last 6 years of live tracking Despite two flat years, the performance over the last 6 years has held up well The asymmetry in outcomes makes it lumpy, but over a full cycle, so far, so good. Let's see if it holds from here🤞
Yet again, the Magic Formula portfolio performance was average in FY25-26, in both absolute and relative terms Metals/Mining contributed to the majority of positive attribution, while IT and Infra dragged the returns FY26-27 Portfolio Link: docs.google.com/spreadsheets…
1
1
9
1,847
Sanjay Kumar Elangovan retweeted
Good numbers from Jio Financials. Strong as expected. Lets see how mkts react .
6
3
40
6,480
US Biotechs with Indian CDMO partners: Esperion (Bluejet/Neuland) New Amsterdam (Piramal/Aarti Pharma) Unicycive (Shilpa/Granules) Biocryst (Sai Life) Vanda (Sai Life) Mineralys (Sai Life) Lantern (Shilpa) Note - US market is brutal. Everything can be discounted in few ticks.
Biotechs in US. Sector to focus on Both technicals and fundamentals pointing here
3
46
1
341
34,063
US FDA has approved Wockhardt's Zaynich (WCK 5222)! This honestly feels like a very personal moment for me. First US FDA approval for an Indian NCE is historic. Wockhardt is a national pride and deserves to be celebrated. Hopefully, this marks the beginning of a pharma innovation cycle in India. Congratulations to everyone who was part of this journey! Over and out. - a rookie analyst from Chennai!
Wockhardt consumed a bit of me and is an example of "Capabilities > Balance Sheet > Income Statement". In fact, the capabilities screwed up the BS and P&L. 😅 I can call myself a (wannabe) "Deep Tech" investor although I am not sure if I will even make money in this.
8
26
2
148
19,973